Key Takeaways
- • Hoxton Farms opened a 14,000-square-foot pilot production facility in Old Street, central London on September 21, 2023, claiming it as the UK's first cultivated animal fat production site with capacity of up to 10 tons per year.
- • The facility is equipped with cell culture laboratories, a food development kitchen, office space, and an on-site workshop for manufacturing proprietary bioreactors designed to reduce capital costs compared to industry-standard equipment.
- • The London-based startup, founded in 2020 by synthetic biologist Dr. Max Jamilly and mathematician Ed Steele, raised $22 million in Series A funding (announced October 2022) led by Collaborative Fund and Fine Structure Ventures, with additional backing from Systemiq Capital, AgFunder, MCJ Collective, and others.
- • Hoxton Farms grows animal fat from stem cells in custom bioreactors, positioning cultivated fat as a critical missing ingredient for plant-based and cultivated meat products, citing fat's essential role in meat's sensory characteristics—aroma, browning, texture, and taste.
- • The company argues that cultivated fat is more scalable than muscle tissue and grows faster, addressing a key consumer pain point: meat alternative products currently lack the organoleptic properties that drive repeat purchases.
Summary
Hoxton Farms, a London-based biotech startup, opened what it describes as the UK's first pilot facility for cultivated animal fat production on September 21, 2023. The 14,000-square-foot facility, located in Old Street in central London, represents the company's first step toward commercial-scale production of lab-grown animal fat for alternative protein applications.
The facility combines multiple functional spaces: cell culture laboratories for growing fat cells, a food development kitchen for product testing and formulation, office and communal areas, and critically, a proprietary workshop for manufacturing custom bioreactors. The company designed these bioreactors in-house to optimize fat cell growth while substantially reducing capital expenditure compared to off-the-shelf industry equipment. The facility is sized to produce up to 10 tons of cultivated fat annually.
Founded in 2020 by synthetic biologist Dr. Max Jamilly and mathematician Ed Steele, Hoxton Farms operates in a nascent but competitive segment of the alternative protein sector. While competitors use microbial engineering or fat structuring technologies like microencapsulation and oleogelation, Hoxton Farms grows animal fat directly from animal cells. Dr. Jamilly has articulated the company's core thesis: fat is the decisive sensory component driving meat's appeal—its aroma, browning capability, texture, and flavor. He contends that current meat alternatives fail to deliver these characteristics, limiting consumer repeat purchases. Cultivated fat, the company argues, is both more scalable and faster-growing than cultivated muscle tissue, making it a pragmatic entry point for cultivated meat ingredients.
The facility was funded through a $22 million Series A round announced in October 2022, led by Collaborative Fund and Fine Structure Ventures. The round also included capital from Systemiq Capital, AgFunder, MCJ Collective, and other investors. The opening of this pilot production facility demonstrates the company's intent to move beyond R&D and begin demonstrating production viability at meaningful scale.
The facility combines multiple functional spaces: cell culture laboratories for growing fat cells, a food development kitchen for product testing and formulation, office and communal areas, and critically, a proprietary workshop for manufacturing custom bioreactors. The company designed these bioreactors in-house to optimize fat cell growth while substantially reducing capital expenditure compared to off-the-shelf industry equipment. The facility is sized to produce up to 10 tons of cultivated fat annually.
Founded in 2020 by synthetic biologist Dr. Max Jamilly and mathematician Ed Steele, Hoxton Farms operates in a nascent but competitive segment of the alternative protein sector. While competitors use microbial engineering or fat structuring technologies like microencapsulation and oleogelation, Hoxton Farms grows animal fat directly from animal cells. Dr. Jamilly has articulated the company's core thesis: fat is the decisive sensory component driving meat's appeal—its aroma, browning capability, texture, and flavor. He contends that current meat alternatives fail to deliver these characteristics, limiting consumer repeat purchases. Cultivated fat, the company argues, is both more scalable and faster-growing than cultivated muscle tissue, making it a pragmatic entry point for cultivated meat ingredients.
The facility was funded through a $22 million Series A round announced in October 2022, led by Collaborative Fund and Fine Structure Ventures. The round also included capital from Systemiq Capital, AgFunder, MCJ Collective, and other investors. The opening of this pilot production facility demonstrates the company's intent to move beyond R&D and begin demonstrating production viability at meaningful scale.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.